Literature DB >> 9566466

Predicting the cost of illness: a comparison of alternative models applied to stroke.

J Lipscomb1, M Ancukiewicz, G Parmigiani, V Hasselblad, G Samsa, D B Matchar.   

Abstract

Predictions of cost over well-defined time horizons are frequently required in the analysis of clinical trials and social experiments, for decision models investigating the cost-effectiveness of interventions, and for macro-level estimates of the resource impact of disease. With rare exceptions, cost predictions used in such applications continue to take the form of deterministic point estimates. However, the growing availability of large administrative and clinical data sets offers new opportunities for a more general approach to disease cost forecasting: the estimation of multivariable cost functions that yield predictions at the individual level, conditional on intervention(s), patient characteristics, and other factors. This raises the fundamental question of how to choose the "best" cost model for a given application. The central purpose of this paper is to demonstrate how to evaluate competing models on the basis of predictive validity. This concept is operationalized according to three alternative criteria: 1) root mean square error (RMSE), for evaluating predicted mean cost; 2) mean absolute error (MAE), for evaluating predicted median cost; and 3) a logarithmic scoring rule (log score), an information-theoretic index for evaluating the entire predictive distribution of cost. To illustrate these concepts, the authors conducted a split-sample analysis of data from a national sample of Medicare-covered patients hospitalized for ischemic stroke in 1991 and followed to the end of 1993. Using test and training samples of about 500,000 observations each, they investigated five models: single-equation linear models, with and without log transform of cost; two-part (mixture) models, with and without log transform, to directly address the problem of zero-cost observations; and a Cox proportional-hazards model stratified by time interval. For deriving the predictive distribution of cost, the log transformed two-part and proportional-hazards models are superior. For deriving the predicted mean or median cost, these two models and the commonly used log-transformed linear model all perform about the same. The untransformed models are dominated in every instance. The approaches to model selection illustrated here can be applied across a wide range of settings.

Entities:  

Mesh:

Year:  1998        PMID: 9566466     DOI: 10.1177/0272989X98018002S07

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  22 in total

1.  An economic cost analysis of oral ganciclovir prophylaxis for the prevention of CMV disease.

Authors:  G G Liu; J Hay
Journal:  Pharm Res       Date:  2000-08       Impact factor: 4.200

2.  Direct medical costs of constipation from childhood to early adulthood: a population-based birth cohort study.

Authors:  Rok Seon Choung; Nilay D Shah; Denesh Chitkara; Megan E Branda; Miranda A Van Tilburg; William E Whitehead; Slavica K Katusic; G Richard Locke; Nicholas J Talley
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-01       Impact factor: 2.839

3.  The impact of home hospitalization on healthcare costs of exacerbations in COPD patients.

Authors:  Jaume Puig-Junoy; Alejandro Casas; Jaume Font-Planells; Joan Escarrabill; Carme Hernández; Jordi Alonso; Eva Farrero; Gemma Vilagut; Josep Roca
Journal:  Eur J Health Econ       Date:  2007-01-13

4.  Longitudinal direct medical costs associated with constipation in women.

Authors:  R S Choung; M E Branda; D Chitkara; N D Shah; S K Katusic; G R Locke; N J Talley
Journal:  Aliment Pharmacol Ther       Date:  2010-11-22       Impact factor: 8.171

5.  The use of patient mix-adjusted control charts to compare in-hospital costs of care.

Authors:  E L Eisenstein; C F Bethea
Journal:  Health Care Manag Sci       Date:  1999-12

6.  Cost differences among robotic, vaginal, and abdominal hysterectomy.

Authors:  Joshua L Woelk; Bijan J Borah; Emanuel C Trabuco; Herbert C Heien; John B Gebhart
Journal:  Obstet Gynecol       Date:  2014-02       Impact factor: 7.661

7.  Smoking status and health care costs in the perioperative period: a population-based study.

Authors:  David O Warner; Bijan J Borah; James Moriarty; Darrell R Schroeder; Yu Shi; Nilay D Shah
Journal:  JAMA Surg       Date:  2014-03       Impact factor: 14.766

8.  Surgeons' economic profiles: can we get the "right" answers?

Authors:  Eric L Eisenstein; Charles F Bethea; Lawrence H Muhlbaier; Marie Davidian; Eric D Peterson; Judith A Stafford; Daniel B Mark
Journal:  J Med Syst       Date:  2005-04       Impact factor: 4.460

9.  Long-term direct costs before and after proctocolectomy for ulcerative colitis: a population-based study in Olmsted County, Minnesota.

Authors:  Stefan D Holubar; Kirsten Hall Long; Edward V Loftus; Bruce G Wolff; John H Pemberton; Robert R Cima
Journal:  Dis Colon Rectum       Date:  2009-11       Impact factor: 4.585

10.  Design of the economic evaluation for the Interventional Management of Stroke (III) trial.

Authors:  Patrick D Mauldin; Kit N Simpson; Yuko Y Palesch; Judy S Spilker; Michael D Hill; Pooja Khatri; Joseph P Broderick
Journal:  Int J Stroke       Date:  2008-05       Impact factor: 5.266

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.